| |
| |
|
| Insider
Information: |
Rubin Michael P. |
| Relationship: |
|
| City: |
Bethesda |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
13,924,362 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$10,287,732 |
|
|
| Total
Shares |
13,924,362 |
|
|
| Total
Value |
$10,287,732 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Telesis Bio Inc |
TBIO |
10% Owner |
2021-06-22 |
0 |
2021-06-22 |
9,844,130 |
Premium* |
|
|
Dice Therapeutics, Inc. |
DICE |
10% Owner |
2021-09-17 |
0 |
2023-06-22 |
166,293 |
Premium* |
|
|
Isoplexis Corp |
ISO |
10% Owner |
2021-10-12 |
0 |
2021-10-12 |
2,080,961 |
Premium* |
|
|
Vigil Neuroscience, Inc. |
VIGL |
10% Owner |
2022-01-11 |
0 |
2022-01-11 |
1,382,978 |
Premium* |
|
|
Kyverna Therapeutics |
KYTX |
|
2024-02-12 |
0 |
2024-02-12 |
450,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIGL |
Vigil Neuroscience, Inc. |
10% Owner |
– – • |
2022-01-11 |
4 |
B |
$14.00 |
$4,970,000 |
I/I |
355,000 |
1,382,978 |
1.5 |
- |
|
| VIGL |
Vigil Neuroscience, Inc. |
10% Owner |
– – • |
2022-01-11 |
4 |
A |
$0.00 |
$0 |
I/I |
3,859,498 |
1,027,978 |
0 |
- |
|
| TBIO |
Telesis Bio Inc |
10% Owner |
– – • |
2021-06-22 |
4 |
B |
$16.00 |
$7,500,000 |
I/I |
468,750 |
9,844,130 |
1.5 |
- |
|
| TBIO |
Telesis Bio Inc |
10% Owner |
– – • |
2021-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
9,375,380 |
9,375,380 |
0 |
- |
|
| KYTX |
Kyverna Therapeutics |
Former 10% Owner |
– – – |
2024-02-12 |
4 |
B |
$22.00 |
$9,900,000 |
I/I |
450,000 |
450,000 |
0.01 |
% |
|
| KYTX |
Kyverna Therapeutics |
Former 10% Owner |
– – – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,805,426 |
2,805,426 |
0 |
- |
|
| ISO |
Isoplexis Corp |
10% Owner |
– – • |
2021-10-12 |
4 |
B |
$15.00 |
$15,000,000 |
I/I |
1,000,000 |
2,080,961 |
1.5 |
- |
|
| ISO |
Isoplexis Corp |
10% Owner |
– – • |
2021-10-12 |
4 |
A |
$0.00 |
$0 |
I/I |
7,344,240 |
1,080,961 |
0 |
- |
|
| DICE |
Dice Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-17 |
4 |
A |
$0.00 |
$0 |
I/I |
3,057,871 |
3,057,871 |
0 |
- |
|
| DICE |
Dice Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-17 |
4 |
B |
$17.00 |
$3,995,000 |
I/I |
235,000 |
3,292,871 |
1.5 |
- |
|
| DICE |
Dice Therapeutics, Inc. |
10% Owner |
– – • |
2023-06-22 |
4 |
S |
$46.50 |
$115,918,502 |
I/I |
(2,492,871) |
166,293 |
0 |
% |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
